nach oben

Tumor Biology

Erschienen in:

29.01.2016 | Original Article

Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors

verfasst von: Rumaisa Rafiq, Gulzar Ahmad Bhat, Mohd Maqbool Lone, Akbar Masood, Nazir Ahmad Dar

Erschienen in: Tumor Biology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

The association of nucleotide excision repair (NER) gene polymorphisms with esophageal squamous cell carcinoma (ESCC) is inconclusive. The aim of the current study was to assess the association of repair gene xeroderma pigmentosum A (XPA) (rs-1800975) and xeroderma pigmentosum C (XPC) (rs-2228000) polymorphisms with ESCC risk as well as modifying effects of environmental factors. The genotyping was done in 450 confirmed ESCC cases and equal number of individually matched controls by the polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) and direct sequencing methods. Conditional logistic regression models were used to assess the genotypic associations and interactions. A high ESCC risk was found in subjects who carried the homozygous minor allele of XPA (odds ratio (OR) = 3.57; 95 % confidence interval (CI) = 1.76–7.23), and the risk was higher when analysis was limited to participants who were ever smokers (OR = 4.22; 95 % CI = 2.01–8.88), lived in adobe houses (OR = 8.42; 95 % CI = 3.74–18.95), consumed large volumes of salt tea (OR = 7.42; 95 % CI = 3.30–16.69), or had a positive family history of cancer (FHC) (OR = 9.47; 95 % CI = 4.67–19.20). In case of XPC, a homozygous minor allele also showed strong association with ESCC risk (OR = 4.43; 95 % CI = 2.41–8.16). We again observed a very strong effect of the above environmental factors in elevating the risk of ESCC. Further, the variant genotypes of both genes in combination showed an increased risk towards ESCC (OR = 7.01; 95 % CI = 3.14–15.64) and such association was synergistically significant. Salt tea consumption showed an interaction with genotypes of XPA and XPC. However, an interaction with FHC was significant in the case of XPA genotype only. XPA and XPC genotypes are associated with an increased risk of ESCC, and such association was reasonably modulated by different exposures.

Nur mit Berechtigung zugänglich

Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science (New York, NY). 2001;291(5507):1284–9. doi:10.1126/science.1056154.CrossRef

Bonn D. How DNA-repair pathways may affect cancer risk. Lancet. 1998;351(9095):42. doi:10.1016/s0140-6736(05)78079-x.PubMedCrossRef

Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366–74. doi:10.1038/35077232.PubMedCrossRef

Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1(1):22–33. doi:10.1038/35094000.PubMedCrossRef

Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999;81(1-2):39–44.PubMedCrossRef

Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene. 2002;21(58):8949–56. doi:10.1038/sj.onc.1206096.PubMedCrossRef

Volker M, Mone MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell. 2001;8(1):213–24.PubMedCrossRef

Au WW, Navasumrit P, Ruchirawat M. Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health. 2004;207(4):301–13. doi:10.1078/1438-4639-00294.PubMedCrossRef

Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25(5):757–63. doi:10.1093/carcin/bgh064.PubMedCrossRef

10.

Pharoah PD, Dunning AM, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer. 2004;4(11):850–60. doi:10.1038/nrc1476.PubMedCrossRef

11.

Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis. 2001;22(4):593–7.PubMedCrossRef

12.

Guo W, Zhou RM, Wan LL, Wang N, Li Y, Zhang XJ, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China. J Cancer Res Clin Oncol. 2008;134(2):263–70. doi:10.1007/s00432-007-0283-0.PubMedCrossRef

13.

Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI, et al. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis. 2011;32(12):1855–61. doi:10.1093/carcin/bgr211.PubMedPubMedCentralCrossRef

14.

Shi Y, Luo GJ, Zhang L, Shi J, Zhang DQ, Chen JM, et al. Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma. PLoS One. 2012;7(9):e43412. doi:10.1371/journal.pone.0043412.PubMedPubMedCentralCrossRef

15.

Park JY, Park SH, Choi JE, Lee SY, Jeon HS, Cha SI, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2002;11(10 Pt 1):993–7.

16.

Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003;24(3):505–9.PubMedCrossRef

17.

Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51(3):343–52. doi:10.1007/bf03208865.PubMedCrossRef

18.

Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2006;15(12):2537–41. doi:10.1158/1055-9965.epi-06-0288.CrossRef

19.

An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, et al. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2007;16(8):1633–8. doi:10.1158/1055-9965.epi-07-0252.CrossRef

20.

Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer J Int Du Cancer. 2005;116(5):768–73. doi:10.1002/ijc.21117.CrossRef

21.

Bai Y, Xu L, Yang X, Hu Z, Yuan J, Wang F, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer. 2007;7:81. doi:10.1186/1471-2407-7-81.PubMedPubMedCentralCrossRef

22.

Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, et al. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 2009;30(5):785–92. doi:10.1093/carcin/bgp058.PubMedPubMedCentralCrossRef

23.

Zhou RM, Li Y, Wang N, Zhang XJ, Dong XJ, Guo W. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Ai zheng = Aizheng = Chin J Cancer. 2006;25(9):1113–9.

24.

Feng XX, Duan PF, Wang LB, Zhang JB, Lu ZX. [Study on the relationship between polymorphisms of XPA gene and susceptibility of esophageal cancer]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2008;29(9):930–3.PubMed

25.

Liu J, Zhang Z, Cao XL, Lei DP, Wang ZQ, Jin T, et al. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis. Mol Biol Rep. 2012;39(6):6791–9. doi:10.1007/s11033-012-1504-4.PubMedCrossRef

26.

He J, Shi TY, Zhu ML, Wang MY, Li QX, Wei QY. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int J Cancer J Int du Cancer. 2013;133(8):1765–75. doi:10.1002/ijc.28089.CrossRef

27.

Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33(1):11–5.PubMedPubMedCentralCrossRef

28.

Dar NA, Bhat GA, Shah IA, Iqbal B, Makhdoomi MA, Nisar I, et al. Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer. 2012;107(9):1618–23. doi:10.1038/bjc.2012.449.PubMedPubMedCentralCrossRef

29.

Dar NA, Bhat GA, Shah IA, Iqbal B, Rafiq R, Nabi S, et al. Salt tea consumption and esophageal cancer: a possible role of alkaline beverages in esophageal carcinogenesis. Int J Cancer J Int du Cancer. 2015;136(6):E704–10. doi:10.1002/ijc.29204.CrossRef

30.

Dar NA, Shah IA, Bhat GA, Makhdoomi MA, Iqbal B, Rafiq R, et al. Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir India. Cancer Sci. 2013;104(9):1231–6. doi:10.1111/cas.12210.PubMedCrossRef

31.

Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, vol. 7.58. New York: Cold Spring Harbor Laboratory; 1989.

32.

Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009;38(4):978–88. doi:10.1093/ije/dyp195.PubMedPubMedCentralCrossRef

33.

Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, et al. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis. 2007;28(3):665–71. doi:10.1093/carcin/bgl160.PubMedCrossRef

34.

Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S, et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2006;35(1):11–8. doi:10.1111/j.1600-0714.2005.00364.x.CrossRef

35.

Bau DT, Tsai MH, Huang CY, Lee CC, Tseng HC, Lo YL, et al. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol. 2007;50(6):294–300.PubMed

36.

Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res: Off J Am Assoc Cancer Res. 2007;13(12):3753–8. doi:10.1158/1078-0432.ccr-06-1911.CrossRef

37.

Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer J Int du Cancer. 2009;125(6):1431–9. doi:10.1002/ijc.24442.CrossRef

38.

Lu B, Li J, Gao Q, Yu W, Yang Q, Li X. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. Gene. 2014;542(1):64–8. doi:10.1016/j.gene.2014.02.043.PubMedCrossRef

39.

Li X, Xu J, Yang X, Wu Y, Cheng B, Chen D, et al. Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35(5):4659–65. doi:10.1007/s13277-014-1610-0.CrossRef

40.

Butkiewicz D, Popanda O, Risch A, Edler L, Dienemann H, Schulz V, et al. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2004;13(12):2242–6.

41.

Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25(12):2433–41. doi:10.1093/carcin/bgh264.PubMedCrossRef

42.

Vogel U, Overvad K, Wallin H, Tjonneland A, Nexo BA, Raaschou-Nielsen O. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett. 2005;222(1):67–74. doi:10.1016/j.canlet.2004.11.016.PubMedCrossRef

43.

Zhu J, Hu Z, Ma H, Huo X, Xu L, Zhou J et al. Polymorphism of the DNA repair gene XPA and susceptibility to lung cancer. 南京医科大学学报. 2005;19(4).

44.

Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27(3):560–7. doi:10.1093/carcin/bgi232.PubMedCrossRef

45.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, et al. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007;631(2):101–10. doi:10.1016/j.mrgentox.2007.03.010.PubMedCrossRef

46.

Raaschou-Nielsen O, Sorensen M, Overvad K, Tjonneland A, Vogel U. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer (Amsterdam, Netherlands). 2008;59(2):171–9. doi:10.1016/j.lungcan.2007.08.018.CrossRef

47.

Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer (Amsterdam, Netherlands). 2011;73(2):138–46. doi:10.1016/j.lungcan.2010.11.018.CrossRef

48.

Zhang W. Effects of genetic and environmental risk factors to esophageal cancer in Huaian population. Master’s thesis. Nanjing, People’s Republic of China. Southeast University. 2006.

49.

Huang X. Polymorphisms of XPA and XRCC3, environmental agent and susceptibilities to esophageal, cardia and non-cardia gastric cancer. Master’s thesis. Fujian Medical University. 2007 (Fujian, People’s Republic of China).

50.

Liu R. Study on expression characteristics of susceptibility genes and genetic susceptibility markers for esophageal carcinomas. PhD thesis. Southeast University. 2007 (Nanjing, People’s Republic of China).

51.

Zhu X. Study on relationship between DNA repair genes polymorphism of hOGG1, XPC, XPA and esophageal squamous cell carcinoma susceptibility. Master’s thesis. Huazhong University of Science and Technology. 2008 (Wuhan, People’s Republic of China).

52.

Zhen Q. XPA gene polymorphisms and susceptibility to developing esophageal cancer in Chinese Han population. Master’s thesis. Zhengzhou University. 2012 (Zhengzhou, People’s Republic of China).

53.

Dong Z, Guo W, Zhou R, Wan L, Li Y, Wang N, et al. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China. J Clin Gastroenterol. 2008;42(8):910–5. doi:10.1097/MCG.0b013e3180f6262c.PubMedCrossRef

54.

Palli D, Polidoro S, D’Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25(6):569–75. doi:10.1093/mutage/geq042.PubMedCrossRef

55.

Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, et al. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res. 2007;619(1-2):68–80. doi:10.1016/j.mrfmmm.2007.02.002.PubMedCrossRef

56.

Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martinez ME, et al. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis. 2009;30(3):472–9. doi:10.1093/carcin/bgn260.PubMedCrossRef

57.

Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, Laczmanska I, et al. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual’s susceptibility to sporadic colorectal cancer. Mol Biol Rep. 2012;39(1):527–34. doi:10.1007/s11033-011-0767-5.PubMedCrossRef

58.

Zou JH, An L, Chen S, Ren LQ. XPA A23G polymorphism and lung cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(2):1435–40. doi:10.1007/s11033-011-0878-z.PubMedCrossRef

59.

He L, Deng T, Luo H. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis. Onco Targets Ther. 2015;8:385–94. doi:10.2147/ott.s75767.PubMedPubMedCentralCrossRef

60.

Wu L, Gao X, Ye D, Ding Y, Yang XI, Liu W. Association of the A23G polymorphism with the risk of head and neck carcinomas: evidence from 5,491 subjects. Mol Clin Oncol. 2015;3(3):649–54. doi:10.3892/mco.2015.513.PubMedPubMedCentral

61.

Yang ZH, Liang WB, Jia J, Wei YS, Zhou B, Zhang L. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Acta Oncol (Stockh). 2008;47(3):379–84. doi:10.1080/02841860701558815.CrossRef

62.

Hu Z, Wang Y, Wang X, Liang G, Miao X, Xu Y, et al. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer J Int du Cancer. 2005;115(3):478–83. doi:10.1002/ijc.20911.CrossRef

63.

Lee GY, Jang JS, Lee SY, Jeon HS, Kim KM, Choi JE, et al. XPC polymorphisms and lung cancer risk. Int J Cancer J Int du Cancer. 2005;115(5):807–13. doi:10.1002/ijc.20900.CrossRef

64.

Hu ZB, Wang YG, Ma HX, Tan W, Niu JY, Lin DX, et al. [Association of two exonic genetic polymorphisms in the DNA repair gene XPC with risk of lung cancer in Chinese population]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin J Med Genet. 2005;22(4):415–8.

65.

Long XD, Ma Y, Huang YZ, Yi Y, Liang QX, Ma AM, et al. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population. China. Mol Carcinog. 2010;49(6):611–8. doi:10.1002/mc.20630.PubMed

66.

Wu Y, Jin M, Liu B, Liang X, Yu Y, Li Q, et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol Carcinog. 2011;50(3):189–98. doi:10.1002/mc.20704.PubMedCrossRef

67.

Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26(7):1263–71. doi:10.1093/carcin/bgi063.PubMedCrossRef

68.

Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78(3):464–79. doi:10.1086/500848.PubMedPubMedCentralCrossRef

69.

de Verdier PJ, Sanyal S, Bermejo JL, Steineck G, Hemminki K, Kumar R. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res. 2010;694(1-2):39–44. doi:10.1016/j.mrfmmm.2010.09.003.PubMedCrossRef

70.

Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. European J Human Genet: EJHG. 2008;16(6):724–34. doi:10.1038/ejhg.2008.6.CrossRef

71.

Qiu L, Wang Z, Shi X. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur J Cancer (Oxford, England: 1990). 2008;44(15):2241–53. doi:10.1016/j.ejca.2008.06.024.CrossRef

72.

Zhang D, Chen C, Fu X, Gu S, Mao Y, Xie Y, et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet. 2008;53(1):18–33. doi:10.1007/s10038-007-0215-5.PubMedCrossRef

73.

Zheng W, Cong XF, Cai WH, Yang S, Mao C, Zou HW. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2011;128(3):811–5. doi:10.1007/s10549-011-1369-6.PubMedCrossRef

74.

Jiang X, Zhou LT, Zhang SC, Chen K. XPC polymorphism increases risk of digestive system cancers: current evidence from a meta-analysis. Chinese J Cancer Res = Chung-kuo yen cheng yen chiu. 2012;24(3):181–9. doi:10.1007/s11670-012-0181-0.CrossRef

75.

Jin B, Dong Y, Zhang X, Wang H, Han B. Association of XPC polymorphisms and lung cancer risk: a meta-analysis. PLoS One. 2014;9(4):e93937. doi:10.1371/journal.pone.0093937.PubMedPubMedCentralCrossRef

76.

Peng Q, Chen Z, Lu Y, Lao X, Mo C, Li R, et al. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis. Diagn Pathol. 2014;9:96. doi:10.1186/1746-1596-9-96.PubMedPubMedCentralCrossRef

77.

Zhang Y, Li Z, Zhong Q, Zhou W, Chen X, Fang J, et al. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35(4):3917–31. doi:10.1007/s13277-013-1520-6.CrossRef

78.

Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell. 1998;2(2):223–32.PubMedCrossRef

79.

Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog. 2003;38(1):1–13. doi:10.1002/mc.10143.PubMedCrossRef

80.

De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 2000;20(21):7980–90.PubMedPubMedCentralCrossRef

81.

Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidem Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2002;11(12):1513–30.

82.

Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000;21(12):2219–23.PubMedCrossRef

83.

Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene. 1999;234(2):187–208.PubMedCrossRef

84.

Kozak M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc Natl Acad Sci U S A. 1995;92(7):2662–6.PubMedPubMedCentralCrossRef

85.

Larsen LK, Amri EZ, Mandrup S, Pacot C, Kristiansen K. Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency. Biochem J. 2002;366(Pt 3):767–75. doi:10.1042/bj20011821.PubMedPubMedCentralCrossRef

86.

Yasuda G, Nishi R, Watanabe E, Mori T, Iwai S, Orioli D, et al. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation. Mol Cell Biol. 2007;27(19):6606–14. doi:10.1128/mcb.02166-06.PubMedPubMedCentralCrossRef

87.

Laczmanska I, Gil J, Karpinski P, Stembalska A, Trusewicz A, Pesz K, et al. Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations. Environ Mol Mutagen. 2007;48(8):666–71. doi:10.1002/em.20333.PubMedCrossRef

88.

Laczmanska I, Gil J, Karpinski P, Stembalska A, Kozlowska J, Busza H, et al. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency. Environ Mol Mutagen. 2006;47(9):666–73. doi:10.1002/em.20253.PubMedCrossRef

89.

Asnaghi L, Alkatan H, Mahale A, Othman M, Alwadani S, Al-Hussain H, et al. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci. 2014;55(12):8604–13. doi:10.1167/iovs.14-14920.PubMedPubMedCentralCrossRef

90.

Best BP. Nuclear DNA, damage as a direct cause of aging. Rejuvenation Res. 2009;12(3):199–208. doi:10.1089/rej.2009.0847.PubMedCrossRef

91.

Sancar A. DNA repair in humans. Annu Rev Genet. 1995;29:69–105. doi:10.1146/annurev.ge.29.120195.000441.PubMedCrossRef

92.

Lindahl T, Wood RD. Quality control by DNA repair. Science (New York, NY). 1999;286(5446):1897–905.CrossRef

93.

Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998;11(6):559–603. doi:10.1021/tx980005y.PubMedCrossRef

94.

Hecht SS, Chen CB, Ohmori T, Hoffmann D. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1980;40(2):298–302.PubMed

95.

Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988;48(23):6912–7.PubMed

96.

Siddiqi M, Tricker AR, Preussmann R. The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Lett. 1988;39(1):37–43.PubMedCrossRef

97.

Siddiqi M, Tricker AR, Preussmann R. Formation of N-nitroso compounds under simulated gastric conditions from Kashmir foodstuffs. Cancer Lett. 1988;39(3):259–65.PubMedCrossRef

98.

Siddiqi MA, Tricker AR, Kumar R, Fazili Z, Preussmann R. Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer --Kashmir India. IARC Sci Publ. 1991;105:210–3.

99.

Petit C, Sancar A. Nucleotide excision repair: from E. coli to man. Biochimie. 1999;81(1-2):15–25.PubMedCrossRef

100.

Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85. doi:10.1146/annurev.biochem.73.011303.073723.PubMedCrossRef

101.

Brown PJ, Bedard LL, Massey TE. Repair of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA pyridyloxobutylation by nucleotide excision repair. Cancer Lett. 2008;260(1-2):48–55. doi:10.1016/j.canlet.2007.10.015.PubMedCrossRef

102.

Morita M, Saeki H, Mori M, Kuwano H, Sugimachi K. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery. 2002;131(1 Suppl):S1–6.PubMedCrossRef

103.

Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer J Int du Cancer. 2006;119(5):1047–51. doi:10.1002/ijc.21906.CrossRef

104.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer J Int du Cancer. 2001;93(1):148–52.CrossRef

105.

Tavani A, Negri E, Franceschi S, La Vecchia C. Risk factors for esophageal cancer in lifelong nonsmokers. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res Am Soc Prev Oncol. 1994;3(5):387–92.

106.

Bhat GA, Shah IA, Rafiq R, Nabi S, Iqbal B, Lone MM, et al. Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India. Br J Cancer. 2015;113(3):524–32. doi:10.1038/bjc.2015.218.PubMedPubMedCentralCrossRef

107.

Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol. 1997;26(6):1159–65.PubMedCrossRef

108.

Li GH, He LJ. A survey on the familial aggregation of esophageal cancer in Yangcheng County. Chin Med J (Engl). 1985;98(10):749–52.

109.

Ko JM, Zhang P, Law S, Fan Y, Song YQ, Zhao XK, et al. Identity-by-descent approaches identify regions of importance for genetic susceptibility to hereditary esophageal squamous cell carcinoma. Oncol Rep. 2014;32(2):860–70. doi:10.3892/or.2014.3222.PubMed

110.

Ayub SG, Ayub T, Khan SN, Rasool S, Mahboob-ul H, Wani KA, et al. Epidemiological distribution and incidence of different cancers in Kashmir valley—2002-2006. Asian Pac J Cancer Prev: APJCP. 2011;12(7):1867–72.PubMed

111.

Fareed M, Afzal M. Estimating the inbreeding depression on cognitive behavior: a population based study of child cohort. PLoS One. 2014;9(10):e109585. doi:10.1371/journal.pone.0109585.PubMedPubMedCentralCrossRef

112.

The International HapMap Project. Nature. 2003;426(6968):789-96. doi: 10.1038/nature02168.

113.

Wang LE, Gorlova OY, Ying J, Qiao Y, Weng SF, Lee AT, et al. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013;73(1):256–64. doi:10.1158/0008-5472.can-12-1915.PubMedCrossRef

114.

Cao S, Wang S, Ma H, Tang S, Sun C, Dai J, et al. Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy. Pharmacogenomics J. 2015. doi:10.1038/tpj.2015.22.

115.

Wang AH, Liu Y, Wang B, He YX, Fang YX, Yan YP. Epidemiological studies of esophageal cancer in the era of genome-wide association studies. World J Gastrointest Pathophysiol. 2014;5(3):335–43. doi:10.4291/wjgp.v5.i3.335.PubMedPubMedCentral

116.

Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010;42(9):759–63. doi:10.1038/ng.648.PubMedCrossRef

117.

Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27(5):997–1007. doi:10.1093/carcin/bgi280.PubMedCrossRef

Titel: Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors
verfasst von: Rumaisa Rafiq
Gulzar Ahmad Bhat
Mohd Maqbool Lone
Akbar Masood
Nazir Ahmad Dar
Publikationsdatum: 29.01.2016
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 8/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-4895-3

Springer Medizin

Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents

C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor

MicroRNA-183 promotes migration and invasion of CD133+/CD326+ lung adenocarcinoma initiating cells via PTPN4 inhibition

Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study

Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology

The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie